SILVERARC CAPITAL MANAGEMENT, LLC CNTA Holdings History
SILVERARC CAPITAL MANAGEMENT, LLC's Centessa Pharmaceuticals PLC Holding Summary
As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held 232,758.00 shares of Centessa Pharmaceuticals PLC(CNTA), totaling $3.35 Mil. This investment constitutes 0.68% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 0.17% of the outstanding Centessa Pharmaceuticals PLC(CNTA) stock.
The initial trade took place in 2024Q3. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 1 purchases of CNTA, at an average price of $12.25, for a total of 744,592.00 shares. In addition, there have been 2 sales at an average price of $16.42 for 511,834.00 shares. Based on historical transaction data and CNTA's current price of $15.57, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his CNTA holdings is $2.91 Mil, reflecting a 31.85% gain to date.
SILVERARC CAPITAL MANAGEMENT, LLC CNTA ($15.57) Holding Chart
SILVERARC CAPITAL MANAGEMENT, LLC CNTA ($15.57) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1